| Application no. and date | 10153374.3 (espacenet) (Federated) (European Patent Register), 20011026 | | Patent/reg. no. and date | DK/EP 2189162, 20131127 | | Publication date | 20100526 | | Priority no. and date | US 246728 P, 20001109 | | EP pub. no. and date |
EP 2189162 20100526 | | Effective date | | | Applicant/owner | Oncolytics Biotech Inc., Suite 210 1167 Kensington Crescent N. W.
Calgary, AB T2N 1X7, CA | | Applicant ref. no. | P53038DK01 | | Inventor | COFFEY, Matthew, C., 2231 Bowness Road, N.W.
Calgary, Alberta T2N 3L4, CA | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 35/76 (2006.01) | | Title | Fremgangsmåder til behandling af cellulære proliferative forstyrrelser | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|